Bioversys N Logo

Bioversys N

BIOV | SW

Overview

Corporate Details

ISIN(s):
CH0210362643 (+1 more)
LEI:
894500UFIGC75NPZEZ68
Country:
Switzerland
Address:
Hochbergerstrasse 60C, 4057 Basel
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Bioversys N, based in Switzerland, is a biotechnology company focused on developing innovative solutions to combat antibiotic resistance.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-02 07:00
M&A Activity
BIOVERSYS AND SHIONOGI ENTER INTO GLOBAL RESEARCH COLLABORATION FOR BROAD-SPECT…
English 21.3 KB
2025-07-02 02:00
M&A Activity
BIOVERSYS AND SHIONOGI ENTER INTO GLOBAL RESEARCH COLLABORATION FOR BROAD-SPECT…
English 16.1 KB
2025-06-30 07:00
Post-Annual General Meeting Information
BIOVERSYS ANNOUNCES RESULTS FROM its ANNUAL GENERAL MEETING OF SHAREHOLDERS
English 10.5 KB
2025-06-30 02:00
Post-Annual General Meeting Information
BIOVERSYS ANNOUNCES RESULTS FROM its ANNUAL GENERAL MEETING OF SHAREHOLDERS
English 6.9 KB
2025-06-03 07:00
Pre-Annual General Meeting Information
BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 20…
English 11.6 KB
2025-06-03 02:00
Pre-Annual General Meeting Information
BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 20…
English 11.0 KB
2025-04-30 00:00
Investor Presentation
BioVersys Corporate Presentation
English 3.2 MB
2025-04-28 07:00
Regulatory News Service
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associa…
English 8.5 KB
2025-04-28 02:00
Report Publication Announcement
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associa…
English 7.2 KB
2025-04-08 07:00
Regulatory News Service
BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025
English 29.7 KB
2025-03-31 07:00
Regulatory News Service
BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE
English 11.6 KB
2025-03-27 07:00
Earnings Release
BIOVERSYS REPORTS CORPORATE HIGHLIGHTS AND KEY FINANCIALS FOR THE FULL YEAR 2024
English 25.6 KB
2025-03-27 00:00
Investor Presentation
Webcast Financial Results 2024 & Business update
English 301.8 KB
2025-03-26 07:00
Earnings Release
BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024
English 30.4 KB
2025-03-26 01:00
Earnings Release
BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024
English 27.1 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioPorto Logo BioPorto Denmark BIOPOR
BioSenic SA Logo BioSenic SA Belgium BIOS
Biosergen AB Logo Biosergen AB Sweden BIOSGN
BIOTECH Logo BIOTECH Spain BST
Biotest AG Logo Biotest AG Germany BIO3
Bioton S.A. Logo Bioton S.A. Poland BIO
Biovica International B Logo Biovica International B Sweden BIOVIC
Bonus BioGroup Ltd. Logo Bonus BioGroup Ltd. Israel BONS
BRAIN Biotech AG Logo BRAIN Biotech AG Germany BNN
BSF ENTERPRISE PLC Logo BSF ENTERPRISE PLC United Kingdom BSFA